Strategic Projects
Initiatives
Useful Links
News
02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...
Innovative Pharmaceutical Initiative – iF!
Delaying Alzheimer’s disease
Scientists are investigating more than 100 new drugs that could enable patients to live more independently.
More pain‑free days for people with migraines
New therapies in development will reduce migraine attacks and enable patients to enjoy a better quality of life.
Preventing infections
Microbiome therapies can prevent the recurrence of infections caused by Clostridium difficile. The number of cases could be reduced by 90%.
Preventing liver transplantation
Therapies for non-alcoholic steatohepatitis can reduce the buildup of fat in the liver. As a result, as many as 12,000 Europeans per year could avoid the need for a liver transplant.
Fight against diabetes
With cell therapies, blood sugar levels could be controlled in nearly 4 million Europeans living with type 1 diabetes.
Creating a world without hemophilia B
Gene therapy can improve the quality of life of people living with disease by reducing the need for intensive, lifelong treatment.
Fighting blood cancer
CAR‑T cell therapy could cure cancers that are currently incurable.
Better prospects for patients with lung cancer
Combination therapy could prevent the deaths of 30,000 people with non-small cell lung cancer.
Fighting bacterial infections
With more than 1,000 medicines in development, antibacterial antibodies could save 25,000 lives every year in Europe.
Bacterial infections
We won't rest until antibacterial monoclonal antibodies succeed in slowing antibiotic resistance and fighting bacterial infections.
Type 1 diabetes
We won't rest until cell therapy replaces regular insulin therapy for patients with diabetes.
Alzheimer’s disease
Alzheimer’s disease is one of the greatest public health crises in Europe, but we will not give up until new treatments stop the progression of the disease.
Lung cancer
Using combination treatment increases their effectiveness, helping people with lung cancer live longer; there will be no respite until non‑small cell lung cancer can be brought under control or even cured.
Haemophilia
Gene therapy offers the potential to transform the lives of patients with haemophilia B, and we will not relent until similar rare diseases can be eased or cured.
Blood cancer
We won't rest until CAR‑T cell therapy helps patients avoid lifelong treatment.
Strategic Projects
National System for Medicine Authentication
Updating the collection of treatment guidelines has been recognized as an important tool for improving healthcare services.
Updating the collection of treatment guidelines has been recognized as an important tool for improving healthcare services.
Initiatives
Disease never sleeps. Neither do we. #WeWontRest in our pursuit of discovering new medicines that can change patients’ lives.
Disease never sleeps. Neither do we. #WeWontRest in our pursuit of discovering new medicines that can change patients’ lives.
The international conference presents experiences and knowledge on the importance of monitoring treatment outcomes for the transformation of healthcare systems
The international conference presents experiences and knowledge on the importance of monitoring treatment outcomes for the transformation of healthcare systems
Clinical trials are scientific and medical trials conducted on healthy or ill subjects who have voluntarily given their consent to
Clinical trials are scientific and medical trials conducted on healthy or ill subjects who have voluntarily given their consent to
Useful Links
Pharmaceutical associations, government agencies, chambers, regulatory bodies, online education, clinical trials, healthcare, medicine, public good
Pharmaceutical associations, government agencies, chambers, regulatory bodies, online education, clinical trials, healthcare, medicine, public good
Zakoni i pravilnici, sastav i programi cijepljenja, statistike, izvješća, najčešća pitanja i odgovori
Zakoni i pravilnici, sastav i programi cijepljenja, statistike, izvješća, najčešća pitanja i odgovori
HeMED (Croatian Electronic Medical Education) is an online platform that provides everyone with free access to verified medical information on desktop or via an app – clearly, accessibly, and in the Croatian language. It is a digital platform used by doctors and patients for ongoing learning and information.
HeMED (Croatian Electronic Medical Education) is an online platform that provides everyone with free access to verified medical information on desktop or via an app – clearly, accessibly, and in the Croatian language. It is a digital platform used by doctors and patients for ongoing learning and information.